MACD Bullish Stocks — Overview View · Medicinal Chemicals & Botanical Products
12 stocks match the MACD Bullish Stocks screen. Stocks whose MACD line is above its signal line — a bullish momentum state, largest first. Overview columns. Filtered to Medicinal Chemicals & Botanical Products. Data as of close · Checked
| DFTX | Definium Therapeutics, Inc. | Healthcare | Medicinal Chemicals & Botanical Products | $4.5B | -12.69 | 33.41 | +2.93% | Bullish | 110K |
| TRLV | Trulieve Cannabis Corp. | Healthcare | Medicinal Chemicals & Botanical Products | $2.2B | -4.66 | 11.52 | +3.78% | Strongly Bullish | 60K |
| CRON | Cronos Group | Healthcare | Medicinal Chemicals & Botanical Products | $1.2B | 17.82 | 3.38 | +1.04% | Strongly Bullish | 73K |
| SNDL | SNDL Inc. | Healthcare | Medicinal Chemicals & Botanical Products | $354M | — | 1.34 | +5.08% | Neutral | 95K |
| CGC | Canopy Growth | Healthcare | Medicinal Chemicals & Botanical Products | $301M | -1.80 | 0.71 | +4.42% | Bearish | 90K |
| ACB | Aurora Cannabis | Healthcare | Medicinal Chemicals & Botanical Products | $290M | — | 5.16 | +22.16% | Bullish | 430K |
| USNA | USANA HEALTH SCIENCES INC | Healthcare | Medicinal Chemicals & Botanical Products | $275M | -12.39 | 14.86 | +1.16% | Bullish | 28K |
| GLAS | Glass House Brands Inc. | Healthcare | Medicinal Chemicals & Botanical Products | $190M | -6.41 | 2.32 | -0.85% | Neutral | 35K |
| NAGE | Niagen Bioscience, Inc. | Healthcare | Medicinal Chemicals & Botanical Products | $187M | 18.25 | 2.36 | -1.67% | Bearish | 43K |
| MDWD | MediWound Ltd. | Healthcare | Medicinal Chemicals & Botanical Products | $173M | — | 13.44 | -0.52% | Bullish | 4K |
| BTMD | biote Corp. | Healthcare | Medicinal Chemicals & Botanical Products | $32M | 5.53 | 1.13 | -0.44% | Bearish | 2K |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | Healthcare | Medicinal Chemicals & Botanical Products | $6M | -0.30 | 1.07 | -3.60% | Bearish | 99 |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.